medRxiv: Acute hepatitis virus likely originated from Covid-19 vaccines

Web site medRxiv disseminated information on the link between Covid-19 vaccines using adenoviral vector technology and the outbreak acute hepatitis among children worldwide.

This is the AstraZeneca (Oxford) vaccine, known in the scientific community as the AZD1222 vaccine, which uses a chimpanzee adenovirus to target the S protein of the new SARS-CoV-2 coronavirus on immune cells and stimulate an immune response.

According to the information posted on the website MedRxiv, the AAV2 virus is the cause of acute hepatitis. The problem is that vaccines are based on adenovirus technology. The virus, which usually does not cause disease and is often present in adenovirus infections, was first associated with the development of acute hepatitis in a small number of young children.

The researchers found very high levels of the virus in the blood and liver patients tested by them, and found to replicate in the liver. In contrast, AAV2 was absent or only present at very low levels in the blood and liver of control children who did not have acute hepatitis.

Two clinical trials conducted independently but in parallel: one studied cases in Scotland by experts from the University Research Center for Virology and Glasgow Royal Children’s Hospital in collaboration with the Scottish public health system and the International Consortium for Severe Acute Respiratory Infections and Emerging Infections (ISARIC), and the second was focused on cases from across the UK and was hosted by the Great Ormond Street Hospital and the Great Ormond Street Institute of Child Health, in collaboration with the UK Health Security Agency.

According to the World Health Organization (WHO), since April last year worldwide, at least 1010 possible cases have been reported in 35 countries. Total registered in Greece 12 casesone of them – A 13-month-old baby who died on July 6th.

The remaining 11 did not require specific treatment and had no complications. According to EODY, these are children aged 14 months, 18 months, 10 years, 5 years, 2 years, 4.5 years, 12 years, 6 years and 5.5 years in the order listed in the EODY epidemiological updates.

Researchers from both groups noticed that AAV2, which cannot replicate without a “helper” virus such as adenovirus or herpesvirus, was present in 96% cases of hepatitis of unknown etiology considered in both studies.

Recall that the AstraZeneca vaccine was banned in Greece after 2 million doses were administered to people in the country. Authorities are extremely reluctant to attribute health complications and deaths from AstraZeneca’s vaccine to administration of the drug.

Source link